SmithKline Beecham's clinical laboratory sales grow 1%:
This article was originally published in Clinica
SmithKline Beecham's third-quarter clinical laboratory sales increased 1% compared with the previous year to £201 million ($320 million). This small growth rate was the result of a 4% volume gain offset by a 3% fall in prices. Third-quarter group sales rose 8% to £1,113 million and trading profit improved to £341 million compared with £280 million in the previous year.